Literature DB >> 16331023

Zone 4 femoral radiolucent lines in hybrid versus cemented total knee arthroplasties: are they clinically significant?

James I Huddleston1, Jeffrey W Wiley, Richard D Scott.   

Abstract

UNLABELLED: Aseptic loosening of the femoral component is an infrequent but important cause of failure in total knee arthroplasties. Inadequate support in the posterior femoral condylar region (radiographic Zone 4) has been associated with loosening. This zone also has been implicated as a site for ingress of wear debris particles leading to osteolysis. We determined the prevalence of Zone 4 radiolucent lines using fluoroscopy to obtain true lateral radiographs in a series of patients who had bilateral simultaneous total knee arthroplasties with a cemented femur on one side and a cementless porous ingrowth femur on the other. We hypothesized that cementless fixation would yield fewer Zone 4 radiolucent lines than cemented fixation. At an average 7.6 +/- 4.4 years followup, 11 of 16 patients (69%) with cemented femoral fixation had Zone 4 radiolucent lines, whereas none of the patients with cementless prostheses had radiolucent lines. Three of 11 radiolucent lines (27%) were progressive. Knee Society scores were similar for both groups. No femoral components in either group were clinically loose. When excellent initial stability was obtained, cementless femoral fixation yielded fewer Zone 4 radiolucent lines compared with cemented fixation. LEVEL OF EVIDENCE: Therapeutic study, Level III (retrospective comparative study). See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331023     DOI: 10.1097/01.blo.0000180452.11048.b8

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  7 in total

1.  Cemented versus uncemented femoral components in total knee arthroplasty.

Authors:  Guillaume Demey; Elvire Servien; Sebastien Lustig; Tarik Aït Si Selmi; Philippe Neyret
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-15       Impact factor: 4.342

2.  Bone-femoral component interface gap after sagittal mechanical axis alignment is filled with new bone after cementless total knee arthroplasty.

Authors:  Shinichi Kuriyama; Katsufumi Hyakuna; Satoshi Inoue; Yasutsugu Kawai; Yasuyuki Tamaki; Hiromu Ito; Shuichi Matsuda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-02-14       Impact factor: 4.342

3.  Distal femur complex fractures in elderly patients treated with megaprosthesis: Results in a case series of 11 patients.

Authors:  Fabio Zanchini; Antonio Piscopo; Valerio Cipolloni; Federico Fusini; Stefano Cacciapuoti; Davide Piscopo; Charlotte Pripp; Luigi Aurelio Nasto; Enrico Pola
Journal:  World J Orthop       Date:  2022-05-18

4.  Long-term Results of Hybrid Total Knee Arthroplasty: Minimum 10-years Follow-up.

Authors:  Young Joon Choi; Ki Won Lee; Chung Hwan Kim; Hyung Sun Ahn; Jae Kwang Hwang; Jeong Ho Kang; Hee Don Han; Wan Jong Cho; Jun Seok Park
Journal:  Knee Surg Relat Res       Date:  2012-05-31

5.  Journey-Deuce bicompartmental knee arthroplasty with the addition of computer navigation achieves good clinical outcomes and implant survival at 10 years.

Authors:  Randeep S Aujla; Jennifer Woodhouse; Jay R Ebert; Michael Finsterwald; Christopher W Jones; Piers Yates; Peter D'Alessandro; David J Wood
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-05-11       Impact factor: 4.114

Review 6.  Cementless versus cemented total knee arthroplasty in young patients: a meta-analysis of randomized controlled trials.

Authors:  Chengyu Chen; Ruodong Li
Journal:  J Orthop Surg Res       Date:  2019-08-19       Impact factor: 2.359

7.  Hybrid total knee arthroplasty revisited: midterm followup of hybrid versus cemented fixation in total knee arthroplasty.

Authors:  Christopher E Pelt; Jeremy M Gililland; Justin Doble; Benjamin M Stronach; Christopher L Peters
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.